{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"8.82","value":"19.8"},{"groupId":"OG001","spread":"15.63","value":"24.1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"title":"Baseline"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"11.50","value":"0.2"},{"groupId":"OG001","spread":"19.47","value":"4.3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"74"},{"groupId":"OG001","value":"41"}],"units":"Participants"}],"title":"Change from Baseline to Week 12"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"8.72","value":"-1.4"},{"groupId":"OG001","spread":"15.66","value":"-0.5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"40"}],"units":"Participants"}],"title":"Change from Baseline to Week 24"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.77","value":"-2.0"},{"groupId":"OG001","spread":"13.92","value":"-0.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"40"}],"units":"Participants"}],"title":"Change from Baseline to Week 36"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.24","value":"-2.3"},{"groupId":"OG001","spread":"18.39","value":"1.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"37"}],"units":"Participants"}],"title":"Change from Baseline to Week 48"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"12.30","value":"-2.5"},{"groupId":"OG001","spread":"17.54","value":"-0.8"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"32"}],"units":"Participants"}],"title":"Change from Baseline to Week 60"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.99","value":"-3.5"},{"groupId":"OG001","spread":"15.50","value":"-6.7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"29"}],"units":"Participants"}],"title":"Change from Baseline to Week 72"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"10.73","value":"-3.0"},{"groupId":"OG001","spread":"18.51","value":"-7.6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"23"}],"units":"Participants"}],"title":"Change from Baseline to Week 84"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"9.25","value":"-5.2"},{"groupId":"OG001","spread":"17.68","value":"-7.4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"25"}],"units":"Participants"}],"title":"Change from Baseline to Week 100"}],"denoms":[{"counts":[{"groupId":"OG000","value":"79"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"description":"uNTx is a biomarker used to measure the rate of bone turnover found in urine.","dispersionType":"Standard Deviation","groups":[{"description":"Participants received 4 mg or a reduced dose, i.e., 3.5 mg, or 3.3 mg or 3.0 mg of Zoledronic acid as an IV infusion over a minimum of 15 minutes every 12 weeks for up to 96 weeks based on the participants most recent urine NTx measurement ( \\<50 nmol/mmol creatinine).","id":"OG000","title":"Zoledronic Acid Every 12 Weeks"},{"description":"Participants received 4 mg or a reduced dose, i.e., 3.5 mg, or 3.3 mg or 3.0 mg of Zoledronic acid as an IV infusion over a minimum of 15 minutes every 4 weeks or every 12 weeks for up to 96 weeks based on the participants most recent urine NTx measurement (≥ 50 nmol/mmol creatinine or \\<50 nmol/mmol creatinine, respectively).","id":"OG001","title":"Zoledronic Acid Every 4 Weeks or 12 Weeks"}],"paramType":"MEAN","populationDescription":"Safety analysis set included all enrolled participants who received at least 1 dose of zoledronic acid. Number analyzed signifies the number of participants with data available for analysis at given time point.","reportingStatus":"POSTED","timeFrame":"Baseline and Weeks 12, 24, 36, 48, 60, 72, 84 and 100/End of Study (EOS)","title":"Change From Baseline in Urinary N-telopeptide of Type 1 Collagen (uNTx)","type":"SECONDARY","unitOfMeasure":"nmol/mmol creatinine"}